NXF-00
Natrix® Q Micro
Synonym(s):
Natrix® Q Membrane Adsorber
Select a Size
$593.00
Select a Size
About This Item
$593.00
Recommended Products
material
media (Macroporous Polymer)
polypropylene device
description
Natrix® Q Micro
product line
Natrix®
packaging
pack of 10 × 0.2 mL (devices)
parameter
1-5 mL/min flow rate
75 psi max. pressure
pore size
0.4 μm pore size
fitting
female inlet and outlet (luer)
application(s)
pharmaceutical
separation technique
strong anion exchange
storage temp.
2-30°C
Looking for similar products? Visit Product Comparison Guide
1 of 4
This Item | MSAMPURO | LIBHV1 | HWGCRISPR |
|---|---|---|---|
| storage temp. −70°C | storage temp. −70°C | storage temp. −70°C | storage temp. −70°C |
| Quality Level 200 | Quality Level - | Quality Level - | Quality Level 200 |
| packaging pkg of 50 μL (96-well plate) | packaging pkg of 40 vials (8x25μL aliquots for each of the 5 kit components) | packaging - | packaging pkg of 8x25 μL (vials) |
| application(s) CRISPR | application(s) CRISPR | application(s) - | application(s) CRISPR |
General description
Application
Biochem/physiol Actions
Features and Benefits
Packaging
Legal Information
related product
Certificates of Analysis (COA)
Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Articles
See case study examples of how to optimize chromatographic purification of plasmid DNA for Biopharmaceutical Applications.
Influenza vaccines are commonly made using egg-based and cell-based manufacturing strategies. Find step-by-step information on the manufacturing process for each method.
A custom-designed cost model is used to explore the economics of vaccine manufacturing across several different modalities including mRNA. The model enables greater process understanding, simulates bottlenecks, and helps to optimize production efficiency.
Learn more one the attenuated viral vaccines manufacturing process: cell culture, clarification, nuclease treatment, chromatography, and sterile filtration.
Related Content
This technical article breaks down the adenovirus vaccine manufacturing process and provides a case study on developing an accelerated and cost-effective single-use adenoviral vector vaccine.
Learn more on mAb downstream processing, more specifically polishing chromatography and the relevant associated products.
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service
